Menu
Recruiting NCT06444503

Clinico-biological Collection of Bone, Calcium and Growth Plate Pathologies

Observational Bone Disorder

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Biological samples, Biological.
Who it may be relevant to
Registry conditions: Bone Disorder. Basic parameters: up to 99 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
France
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Creation of a Biological Collection to Study the Pathophysiology and Identify Predictive Factors for the Evolution of Bone, Calcium and Growth Plate Pathologies

Overview

The aim of this project is to set up a biological and clinical collection of patients with progressive bone, calcium and growth plate pathologies. This collection will provide a better understanding of the mechanisms involved in growth plate and bone damage in these diseases and identify factors predictive of progression and new therapeutic targets.

Interventions

  • Other Biological samples
    Blood and urine will be taken in larger quantity
  • Other Biological
    Surgical residues may be preserved in the event of surgery carried out as part of the treatment.

Primary outcome measures

  • Building a collection of biological samples and clinical-biological data from patients presenting bone, calcium and growth plate pathologies [Time frame: Day 0 and through study completion, an average of 5 years]
Secondary outcome measures (1)
  • Identification of potential markers of disease progression based on new knowledge. [Time frame: Day 0 and through study completion, an average of 5 years]

Eligibility criteria

Inclusion criteria

  • Children (from birth) with growth plate or bone pathology
  • Patients affiliated to or benefiting from a social security scheme
  • Patients able to receive information about the study and to understand the information form in order to participate in the study. This implies :
  • mastery of the French language
  • Not being subject to a restriction of rights by the judicial authorities
  • Patients or legal representatives having given their consent to participate in the study (expression of non-opposition).

Exclusion criteria

  • Patients under legal protection (guardianship, curatorship or safeguard of justice)
  • Pregnant or breast-feeding women

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Cohort

Study locations

France · 1 center
  • University Toulouse Hospital — Toulouse

Identifiers

NCT: NCT06444503 · RC31/24/0214

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗